104 related articles for article (PubMed ID: 2108838)
21. In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination.
Paulsen JE; Lützow-Holm C
Anticancer Res; 2000; 20(5B):3485-9. PubMed ID: 11131651
[TBL] [Abstract][Full Text] [Related]
22. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
23. Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment.
Seidenfeld J; Komar KA; Naujokas MF; Block AL
Cancer Res; 1986 Mar; 46(3):1155-9. PubMed ID: 3080235
[TBL] [Abstract][Full Text] [Related]
24. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
Oredsson SM; Deen DF; Marton LJ
Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
[TBL] [Abstract][Full Text] [Related]
25. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
26. Effect of alpha-difluoromethylornithine alone and in combination with doxorubicin hydrochloride, cis-diamminedichloroplatinum (II), and vinblastine sulfate on the growth of P3J cells in vitro.
Allen ED; Natale RB
Cancer Res; 1986 Jul; 46(7):3550-5. PubMed ID: 3085924
[TBL] [Abstract][Full Text] [Related]
27. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
[TBL] [Abstract][Full Text] [Related]
28. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
Marx M; Townsend CM; Barranco SC; Glass EJ; Thompson JC
J Natl Cancer Inst; 1987 Sep; 79(3):543-8. PubMed ID: 3114535
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
[TBL] [Abstract][Full Text] [Related]
32. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.
Herr HW; Warrel RP; Burchenal JH
Urology; 1986 Dec; 28(6):508-11. PubMed ID: 3097903
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
[TBL] [Abstract][Full Text] [Related]
35. Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors.
Pereira MA; Tao L; Wang W; Li Y; Umar A; Steele VE; Lubet RA
Carcinogenesis; 2004 Oct; 25(10):1917-23. PubMed ID: 15205357
[TBL] [Abstract][Full Text] [Related]
36. Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.
Grossie VB; Ota DM; Ajani JA; Chang TH; Patenia D; Nishioka K
Cancer Res; 1989 Aug; 49(15):4159-62. PubMed ID: 2501023
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
[TBL] [Abstract][Full Text] [Related]
38. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Pegg AE; Magee PN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):191-9. PubMed ID: 11303587
[TBL] [Abstract][Full Text] [Related]
39. Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of alpha-difluoromethylornithine and recombinant gamma-interferon.
Gohji K; Murao S; Maeda S; Sugiyama T; Kamidono S
Cancer Res; 1986 Dec; 46(12 Pt 1):6264-8. PubMed ID: 3096559
[TBL] [Abstract][Full Text] [Related]
40. Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor.
Herr HW; Kleinert EL
Prostate; 1984; 5(4):439-44. PubMed ID: 6429652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
